Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AEMPS · 3 medicines
SFDA · 2 medicines · Historical list
FDA · 2 medicines
AIFA · 1 medicine
CBG-MEB · 1 medicine
TFDA · 1 medicine · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
2 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Danazol | United States | 100MG, 200MG, 50MG | capsule | Marketed | Barr |
| Danocrine | United States | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | capsule | Not marketed | Sanofi Aventis US |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, FDA, Health Canada, HSA, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
